Skip to main content
Caplight Logo









PherDal Fertility Science

PherDal Fertility Science

Private
Dixon, IllinoisHealthcare & Life Scienceshttps://pherdal.com/

Last Round

Debt

Dec 15, 2023

Est. Valuation

$14.64M

Total Funding Raised

$950,000

Company Overview

PherDal Fertility Science is a medical device company that produces the first and only sterile, FDA-cleared, at-home insemination kit designed to bridge the gap between home conception and invasive clinical infertility treatments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, E-commerce, Telemedicine

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

intracervical inseminationICIat-home inseminationfertility kitDIY inseminationmedical deviceFDA-clearedfertility treatmentDTC fertilityreproductive healthinfertility assistanceat-home fertilitytelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PherDal Fertility Science Comparables

Compare PherDal Fertility Science with similar companies based on industry and business-model similarity.

PherDal Fertility Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mosie Baby
92%
MakeAMom
91%
Rinovum Women's Health
86%

PherDal Fertility Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtDec 15, 2023
AcceleratorDec 13, 2023
CrowdfundingDec 19, 2022

Key People

Founding team and executive leadership

Jennifer Hintzsche

CEO & Founder

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 15, 2023

    $320K debt round completed.

PherDal Fertility Science Filings

Explore SEC and related filing metadata, where available.

PherDal Fertility Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PherDal Fertility Science's valuation, stock price, and market status.

Is PherDal Fertility Science a public or private company?

PherDal Fertility Science is a private company.

What is the current stock price of PherDal Fertility Science?

PherDal Fertility Science is a private company with no public stock price. No recent secondary market data is available.

How much is PherDal Fertility Science worth (valuation)?

PherDal Fertility Science's valuation is estimated at $14.6M based on funding round data.

Can I buy PherDal Fertility Science stock?

PherDal Fertility Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PherDal Fertility Science's last funding round?

PherDal Fertility Science's most recent funding round was Debt on December 19, 2022.

Who are the main investors in PherDal Fertility Science?

Investor information for PherDal Fertility Science is not publicly disclosed.

Will PherDal Fertility Science IPO soon?

No public IPO plans have been announced for PherDal Fertility Science.

How can I track PherDal Fertility Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PherDal Fertility Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDixon, Illinois
Employee Range4
Year Founded2022
Last FundingDec 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?